Other potential serum biomarkers under investigation include circulating tumor cells (CTCs) [15,16], tumor mutational burden (TMB) [17], circulating tumor DNA (ctDNA) [8], soluble Granzyme B [18], microRNA (miRNA) [19], blood microbiome [20], and exosomes [21]. The gene discussed is GZMB; the disease is neoplasm.